Patients with candidemia and/or invasive candidiasis

Clinical trials for Patients with candidemia and/or invasive candidiasis explained in plain language.

Never miss a new study

Get alerted when new Patients with candidemia and/or invasive candidiasis trials appear

Sign up with your email to follow new studies for Patients with candidemia and/or invasive candidiasis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

A multi-centre, randomized, double-blind, active controlled, parallel groups, phase II study to evaluate the efficacy and safety of intravenous HRS9432 in the treatment of subjects with candidemia and/or invasive candidiasis

Completed

The Purpose of this study is to evaluate the efficacy and safety of intravenous HRS9432 in patients with candidemia and/or invasive candidiasis

Matched conditions: PATIENTS WITH CANDIDEMIA AND/OR INVASIVE CANDIDIASIS

Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Last updated Sep 10, 2026 16:00 UTC

Patients with candidemia and/or invasive candidiasis

Get alerted when new Patients with candidemia and/or invasive candidiasis trials appear

A multi-centre, randomized, double-blind, active controlled, parallel groups, phase II study to evaluate the efficacy and safety of intravenous HRS9432 in the treatment of subjects with candidemia and/or invasive candidiasis